Reader devices for optical and electrochemical test devices

Patent metadata

Field	Value
Publication number	US-9488585-B2
Application number	US-201514919377-A
Country	US
Kind code	B2
Filing date	Oct 21, 2015
Priority date	Dec 23, 2011
Publication date	Nov 8, 2016
Grant date	Nov 8, 2016

Abstract

This invention relates generally to devices and methods for performing optical and electrochemical assays and, more particularly, to devices having optical and electrochemical detectors and to methods of performing optical and electrochemical assays using such devices. The present invention is particularly useful for performing immunoassays and/or electrochemical assays at the point-of-care.

First claim

We claim:

1. An instrument comprising:
a housing including a cartridge receiving port configured to receive a plurality of testing cartridges, wherein said plurality of testing cartridges comprises at least two selected from the group consisting of: a qualitative or semi-quantitative lateral flow test device; a quantitative non-lateral flow test device; and a combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device;
an optical sensor within said port configured to read a first signal from an optical feature of said qualitative or semi-quantitative lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device; and
an electrical connector within said port configured to mate with one or more electrodes of said quantitative non-lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device.

2. The instrument of claim 1 , wherein said qualitative or semi-quantitative lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and said quantitative non-lateral flow test device comprises a testing system operable to detect an analyte selected from the group consisting of: hCG and drugs of abuse.

3. The instrument of claim 1 , wherein said quantitative non-lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and said quantitative non-lateral flow test device comprises a testing system operable to detect an analyte selected from the group consisting of: hCG, K, Na, Cl, Ca, Mg, pH, pO2, pCO2, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate and ALP.

4. The instrument of claim 1 , wherein said qualitative or semi-quantitative lateral flow test device; said quantitative non-lateral flow test device; and said combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device are configured to test for a predetermined analyte in a biological sample selected from the group consisting of: urine, blood, plasma, serum, and amended forms thereof.

5. An analyte testing system comprising:
a plurality of testing cartridges including at least two selected from the group consisting of: a qualitative or semi-quantitative lateral flow test device; a quantitative non-lateral flow test device; and a combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device; and
an instrument including:
a housing with a cartridge receiving port configured to receive said plurality of testing cartridges;
a first detector comprising an electrical connector configured to connect to a quantitative electrochemical sensor in at least one of said plurality of testing cartridges; and
a second detector comprising an optical imager configured to image an optical assay in at least one of said plurality of testing cartridges.

6. The instrument of claim 5 , wherein said qualitative or semi-quantitative lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and said quantitative non-lateral flow test device comprises a testing system operable to detect an analyte selected from the group consisting of: hCG and drugs of abuse.

7. The instrument of claim 5 , wherein said quantitative non-lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and said quantitative non-lateral flow test device comprises a testing system operable to detect an analyte selected from the group consisting of: hCG, K, Na, Cl, Ca, Mg, pH, pO2, pCO2, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate and ALP.

8. The instrument of claim 5 , wherein said qualitative or semi-quantitative lateral flow test device; said quantitative non-lateral flow test device; and said combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device are configured to test for a predetermined analyte in a biological sample selected from the group consisting of: urine, blood, plasma, serum, and amended forms thereof.

9. An instrument comprising: a connector configured to mate with electrical contacts of at least two test devices selected from the group consisting of: a qualitative or semi-quantitative lateral flow test device; a quantitative non-lateral flow test device; and a combined qualitative or semi-quantitative lateral flow test device and a quantitative non-lateral flow test device; and
an imager configured to image a detection zone on a lateral flow test strip on the qualitative or semi-quantitative lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and the quantitative non-lateral flow test device.

10. The instrument of claim 9 , wherein said imager is further configured to image a two-dimensional barcode adjacent said detection zone on said qualitative or semi-quantitative lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and the quantitative non-lateral flow test device.

11. The instrument of claim 10 , wherein the imager is further configured to image said two-dimensional barcode and said detection zone at a same time.

12. The instrument of claim 11 , wherein said electrical contacts are connected to a quantitative electrochemical sensor in said quantitative non-lateral flow test device or said combined qualitative or semi-quantitative lateral flow test device and the quantitative non-lateral flow test device.

Assignees

• Abbott Point Of Care Inc

Inventors

• Emeric Pierre
• Davis Graham
• Ewart Thomas
• Gershtein Sergey

Classifications

• G01N2021/751

  Comparing reactive/non reactive substances · CPC title

• G01N2035/00752

  bar codes · CPC title

• G01N33/48

  Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02) · CPC title

• G01N2021/757

  using immobilised reagents · CPC title

• G01N2021/7763

  Sample through flow · CPC title